205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.78%
Revenue growth at 50-75% of LSCC's 8.00%. Martin Whitman would worry about competitiveness or product relevance.
1.19%
Gross profit growth under 50% of LSCC's 7.50%. Michael Burry would be concerned about a severe competitive disadvantage.
8.44%
EBIT growth 50-75% of LSCC's 12.90%. Martin Whitman would suspect suboptimal resource allocation.
8.44%
Operating income growth at 50-75% of LSCC's 12.90%. Martin Whitman would doubt the firm’s ability to compete efficiently.
3.96%
Net income growth under 50% of LSCC's 11.36%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.56%
EPS growth at 50-75% of LSCC's 8.33%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
5.56%
Diluted EPS growth at 50-75% of LSCC's 8.33%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.59%
Share reduction more than 1.5x LSCC's 1.64%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.84%
Diluted share count expanding well above LSCC's 1.64%. Michael Burry would fear significant dilution to existing owners' stakes.
38.32%
Dividend growth of 38.32% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
30.10%
OCF growth under 50% of LSCC's 66.23%. Michael Burry might suspect questionable revenue recognition or rising costs.
26.88%
FCF growth under 50% of LSCC's 133.33%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
129.53%
10Y revenue/share CAGR under 50% of LSCC's 614.09%. Michael Burry would suspect a lasting competitive disadvantage.
77.01%
5Y revenue/share CAGR at 50-75% of LSCC's 131.17%. Martin Whitman would worry about a lagging mid-term growth trajectory.
44.21%
3Y revenue/share CAGR at 50-75% of LSCC's 80.12%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
2867.62%
5Y OCF/share CAGR above 1.5x LSCC's 79.66%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.90%
3Y OCF/share CAGR under 50% of LSCC's 65.69%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
378.63%
10Y net income/share CAGR of 378.63% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
3684.73%
5Y net income/share CAGR above 1.5x LSCC's 154.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
303.89%
3Y net income/share CAGR above 1.5x LSCC's 113.50%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
37.08%
Below 50% of LSCC's 170.37%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
53.77%
3Y equity/share CAGR at 50-75% of LSCC's 95.91%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
20.80%
Dividend/share CAGR of 20.80% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
10.83%
3Y dividend/share CAGR of 10.83% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.60%
AR growth is negative/stable vs. LSCC's 49.28%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
5.04%
Inventory shrinking or stable vs. LSCC's 27.11%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.58%
Asset growth at 50-75% of LSCC's 12.39%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
7.55%
1.25-1.5x LSCC's 6.46%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
4.60%
Debt growth of 4.60% while LSCC is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
2.79%
R&D growth drastically higher vs. LSCC's 4.69%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-5.72%
We cut SG&A while LSCC invests at 4.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.